19 results match your criteria: "The University of North Carolina Eshelman School of Pharmacy[Affiliation]"

Objective: To explore the experiences, contributions, and perceived legacy of individuals recognized as leaders in the pharmacy profession and compare these by gender and generational category.

Methods: A total of 54 leaders were interviewed about their journey to leadership and the legacy they leave to the profession. Interviews were transcribed, de-identified, and qualitatively analyzed using an inductive, modified constant comparison approach for open and axial coding.

View Article and Find Full Text PDF

Objective: The purpose of this study was to develop and assess an easily accessible interprofessional mobile web application to assist preceptors with challenging teaching and learning situations.

Methods: Phase 1 was a modified Delphi process of 48 advanced practice nursing, dentistry, medicine, and pharmacy preceptors to determine the content of the application. Phase 2 consisted of 12 preceptors from the 4 disciplines piloting a prototype to refine the tool using design-thinking principles.

View Article and Find Full Text PDF

Oncology Pharmacists Help Bridge the Gap to Optimize Precision Oncology Services for Veterans With Cancer.

JCO Oncol Pract

August 2023

Jill S. Bates, PharmD National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Department of Practice Advancement and Clinical Education, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, Pharmacy Service, Durham VA Medical Center, Durham, NC; Jennifer Piccolo, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, William S. Middleton Memorial Veterans Hospital, Madison, WI; Bailey Crandall, PharmD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Pharmacy Service, Ralph H. Johnson VA Medical Center, Charleston, SC; and Michael J. Kelley, MD, National Oncology Program, Specialty Care Services, Department of Veterans Affairs, Washington DC, Hematology-Oncology, Durham VA Medical Center, Durham, NC, Department of Medicine, Duke Cancer Institute & Medical Oncology, Duke University, Durham, NC.

View Article and Find Full Text PDF

The impact of pharmacy benefit managers on community pharmacy: A scoping review.

Explor Res Clin Soc Pharm

June 2023

Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, SC, United States of America.

Introduction: The introduction of pharmacy benefit managers (PBMs) within the United States healthcare system occurred with the aim to decrease costs and increase quality. News media and legislation have painted a picture of decreased pharmacy competition and potential negative impacts on patients and their access to affordable medications.

Objective: The objective of this scoping review was to evaluate the current research literature examining the impact of PBMs on the finances of community pharmacies.

View Article and Find Full Text PDF

Evidence indicates an increasing shortage of dentists in communities across the United States with potentially significant implications for oral health, as well as overall health and well-being. One strategy to increase access to dental care in rural and underserved communities is community-based postgraduate dental training. However, developing new dental programs requires navigating complex accreditation, financial and community governance, among other, barriers.

View Article and Find Full Text PDF

Interested in situational judgment tests? Preparing pharmacy educators for potential challenges.

Curr Pharm Teach Learn

June 2022

Division of Practice Advancement and Clinical Education, The University of North Carolina Eshelman School of Pharmacy, 301 Pharmacy Lane, Chapel Hill, NC 27599, United States. Electronic address:

Purpose: There is a growing interest in situational judgment tests (SJTs) for assessments and the authors offer their insights to help others develop and utilize these instruments while navigating common challenges.

Description: This manuscript provides important considerations to those interested in SJTs using the "What? So What? Now What?" reflection framework. The authors offer their experience developing, implementing, and evaluating SJTs designed to measure empathy, adaptability, and integrity.

View Article and Find Full Text PDF

Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity.

CPT Pharmacometrics Syst Pharmacol

June 2022

Division of Pharmacotherapy and Experimental Therapeutics, The University of North Carolina Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Obesity is an increasingly alarming public health threat, with nearly 20% of children classified as obese in the United States today. Children with obesity are commonly prescribed the opioids fentanyl and methadone, and accurate dosing is critical to reducing the risk of serious adverse events associated with overexposure. However, pharmacokinetic studies in children with obesity are challenging to conduct, so there is limited information to guide fentanyl and methadone dosing in these children.

View Article and Find Full Text PDF

Wolcott provides guidance on where we can start the healing process in healthcare by emphasizing an environment in which growth mindsets can flourish.

View Article and Find Full Text PDF

What Is Known And Objective: Direct oral anticoagulants (DOACs) are increasingly prescribed instead of warfarin for chronic anticoagulation for ease of dosing, fewer interactions, and less stringent monitoring. However, it is important to consider indications and comorbidities for which warfarin is still the preferred anticoagulant. This review aims to capture these clinical scenarios in which warfarin may still be preferred over DOACs.

View Article and Find Full Text PDF

Background: Situational judgment tests (SJTs) are used in health sciences education to measure examinee knowledge using case-based scenarios. Despite their popularity, there is a significant gap in the validity research on the response process that demonstrates how SJTs measure their intended constructs. A model of SJT response processes has been proposed in the literature by Robert Ployhart; however, few studies have explored and expanded the factors.

View Article and Find Full Text PDF

Cannabis related online searches are associated with positive attitudes toward medical cannabis, particularly when information is obtained from dispensaries. Since pain is the main reason for medicinal cannabis use, information from dispensary websites has the potential to shape the attitude of pain patients towards cannabis. This is relevant because cannabis has demonstrated efficacy in neuropathic pain with low tetrahydrocannabinol (THC) concentrations (< 5-10%), in contrast to potent cannabis (>15% THC), which is highly rewarded in the recreational realm.

View Article and Find Full Text PDF

Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED).

J Am Board Fam Med

August 2021

From the University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC (JJ); Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC (AFB).

Background: In 2015, Vyvanse (lisdexamfetamine) became the first Food and Drug Administration (FDA)-approved treatment for binge-eating disorder (BED), a condition first recognized by the DSM-V in 2013. Because pharmaceutical companies use continuing medical education (CME) to help sell drugs, we explored possible bias in CME modules on BED.

Methods: We utilized a qualitative thematic analysis research approach to identify and classify patterns in CME activities focusing on BED.

View Article and Find Full Text PDF

Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine.

J Pharmacol Exp Ther

November 2019

Departments of Physiology and Pharmacology (S.W.K., A.N.W., J.D.G., K.W., D.P.S., V.S.), Neuroscience, and Behavioral Medicine and Psychiatry (V.S.), West Virginia University School of Medicine, Morgantown, West Virginia; Department of Psychology, West Virginia University Eberly College of Arts and Sciences, Morgantown, West Virginia (K.R.T., S.G.K.); Department of Medicinal Chemistry, The University of Kansas School of Pharmacy, Lawrence, Kansas (T.E.P.); Division of Chemical Biology and Medicinal Chemistry, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina (A.A.H., J.A.); and Department of Pharmacology, The University of North Carolina School of Medicine, Chapel Hill, North Carolina (T.K.)

Mu opioid receptor (MOR)-targeting analgesics are efficacious pain treatments, but notorious for their abuse potential. In preclinical animal models, coadministration of traditional kappa opioid receptor (KOR)-targeting agonists with MOR-targeting analgesics can decrease reward and potentiate analgesia. However, traditional KOR-targeting agonists are well known for inducing antitherapeutic side effects (psychotomimesis, depression, anxiety, dysphoria).

View Article and Find Full Text PDF

Deferiprone (DFP) is a hydroxypyridinone-derived iron chelator currently in clinical use for iron chelation therapy. DFP has also been known to elicit antiproliferative activities, yet the mechanism of this effect has remained elusive. We herein report that DFP chelates the Fe ion at the active sites of selected iron-dependent histone lysine demethylases (KDMs), resulting in pan inhibition of a subfamily of KDMs.

View Article and Find Full Text PDF

Genetic Variants of and Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib.

Cancer Res

January 2019

Division of Pharmacotherapy and Experimental Therapeutics, Center for Pharmacogenomics and Individualized Therapy, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina.

Article Synopsis
  • The study aimed to identify genetic markers that could predict survival in patients with metastatic renal cell carcinoma (mRCC) treated with sorafenib, as such markers were previously unavailable.
  • A total of 295 patients were genotyped for variants in 56 genes, with specific variants linked to shorter overall survival found, including rs1885657, ITGAV rs3816375, and WWOX rs8047917.
  • Mechanistic studies revealed that certain genetic variants enhanced receptor activity and reduced the efficacy of sorafenib, suggesting that genetic variations may influence patient outcomes and warrant further investigation in other cancer treatments.
View Article and Find Full Text PDF

Insulin use, adipokine profiles and breast cancer prognosis.

Cytokine

January 2017

State University of New York at Buffalo, Department of Pharmacy Practice, New York State Center of Excellence in Bioinformatics and Life Sciences, 701 Ellicott Street, Buffalo, NY 14203, United States; Roswell Park Cancer Institute, Department of Pharmacy Services, Elm & Carlton Streets, Buffalo, NY 14263, United States. Electronic address:

Background: Type-2 diabetes mellitus (T2DM) and breast cancer (BC) share common cytokine signaling changes resultant from adipose tissue dysfunction. This modified adipokine signaling was shown to be directly associated with changes in the body mass index (BMI) and diet and it is expected to also be influenced by T2DM pharmacotherapy. We evaluated the relationship between pre-existing diabetes treatment, circulating adipokine levels at cancer diagnosis, and long-term outcomes.

View Article and Find Full Text PDF

Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.

Nat Genet

September 2014

1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. [2].

We performed a multistage genome-wide association study including 7,683 individuals with pancreatic cancer and 14,397 controls of European descent. Four new loci reached genome-wide significance: rs6971499 at 7q32.3 (LINC-PINT, per-allele odds ratio (OR) = 0.

View Article and Find Full Text PDF

A new look at established therapies: practical tools for optimizing insulin use.

Diabetes Educ

September 2010

The University of North Carolina Eshelman School of Pharmacy, Duke University Hospital, and Duke Area Health Education Centers, Durham, NC (Mr Rodgers)

Purpose: Current evidence shows early initiation of insulin therapy in type 2 diabetes mellitus (T2DM) improves glycemic control, responsiveness to subsequent oral antidiabetic therapies, beta-cell function, and possible cardiovascular outcomes. The American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) 2008 algorithm introduces insulin therapy earlier in the treatment of T2DM with prompt intensification to achieve therapeutic goals. Agent selection and insulin regimens are based on patient A1C levels and willingness to monitor blood glucose, use of previous medications, blood glucose patterns, diet, and lifestyle.

View Article and Find Full Text PDF